Minaris Regenerative Medicine, LLC services

Minaris Regenerative Medicine’s policy is to establish a quality culture founded in trust and integrity that is demonstrated through our approach to our people, our systems, our clients, patients, and ourselves.

Regardless of the type of cell therapy product or the medical indication, the production of cell-based therapeutics is highly complex. Minaris Regenerative Medicine offers you comprehensive manufacturing experience, fully compliant with the relevant regional regulatory requirements of our global facilities in North America, Europe, and Asia.

Minaris Regenerative Medicine’s manufacturing development services help you to design efficient and robust manufacturing processes for your cell and gene therapy. Keeping the ultimate goal of commercial supply in mind, we help you think beyond your current manufacturing needs to create approaches that improve the commercial viability of your products. We keep in mind four key elements of commercial viability – quality, scalability, sustainability and cost of goods – the critical drivers of successful commercial cell therapy manufacturing.

To ensure we provide the best possible service to you, Minaris Regenerative Medicine and our cell & gene therapy specialists offer guidance at every stage of your process.

Quality control and quality assurance are essential elements of Minaris Regenerative Medicine’s production, ensuring the quality and consistency of every batch of product. Each step of the manufacturing process is strictly controlled and carefully documented. Through external GMP/GLP audits performed by our trained personnel, we ensure that all external partners fully comply with regulatory standards and with our own stringent requirements.